VERDUO


Oral spray solution
2,7mg/dose
2,5mg/dose
3 x 10ml

THC/CBD is indicated as treatment for symptom improvement in adult patients with moderate to severe spasticity due to multiple sclerosis (MS) who have not responded adequately to other anti-spasticity medication and who demonstrate clinically significant improvement in spasticity related symptoms during an initial trial of therapy.

Physicians throughout EU are prescribing THC/CBD oral spray solution as an initial treatment to determine patient tolerance, and for a number of off label causes ranging from pain, to sleep, stressrelief and concentration.

VERDUO is a generic THC/CBD-format - for oral ingestion.

Did you know?


  • THC is a controlled substance.
  • As with antibiotics, all patients do not tolerate cannabinoids well.
  • Cannabinoids are non-toxic.
  • There are 3 main types of cannabinoids; Endogenous, Phyto- and Synthetic.
  • Cannabinoids have broad therapeutical & medical potential.
  • Research on FAAH and endocannabinoids is revolutionizing endocrinology, as well as research in pain and neuropsychiatry.
  • There are up to 70 million patients in the EU who could benefit from cannabinoid formats.
  • In Germany, today more than 60000 patients recieve prescribed medical cannabinoid formats for a wide range of symtpom relief.
  • In the UK physicians have advised that cannabis-based medicines that contain THC should be used in place of opioid medications.

THC is potentially aversive to people suffering from psychotic states or is diagnosed with mental illness.
THC is potentially addictive for sensitive patients.
THC interacts with Warfarin.
Do not use cannabinoid products without first consulting your physician.

Cannabinoid API

Cannabinoids derived from the flower of the Cannabis Sativa Sativa (L.) has been found to have therapeutic medical use and is showing great potential for treating diseases or conditions. The cannabis plant contains more than 100 different chemicals known as cannabinoids; each one has a varying effect.


Delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are the two cannabinoids that have been researched the most.

THC & CBD are typically the two cannabinoids that administered within medications.


Today research is being conducted all around the world to see if cannabis-based medicines could be used for clinical treatments of an array of diseases such as:

  • Alzheimer’s
  • Appetite issues
  • Arthritis
  • Cancer
  • Crohn’s disease
  • Fibromyalgia
  • Epilepsy
  • Glaucoma
  • Mental health conditions like posttraumatic stress disorder (PTSD)
  • Nausea
  • Pain
  • Rheumatoid arthritis
  • Seizures